Elizabeth Holmes was the founder and CEO of Theranos, a blood‑testing startup that collapsed after it emerged that the company had massively misled investors, partners, and patients about what its technology could actually do. She was later convicted of multiple counts of fraud related to this deception.

Who Elizabeth Holmes Is

Elizabeth Holmes is a former Silicon Valley entrepreneur who dropped out of Stanford University in her early 20s to start Theranos in 2003. She positioned herself as a visionary aiming to revolutionize blood testing with a small device that could supposedly run hundreds of tests from just a finger‑prick of blood.

What Theranos Claimed To Do

Theranos claimed its proprietary machines could deliver fast, accurate lab results from a tiny blood sample, far less than conventional blood draws. The company marketed this as a way to make healthcare more accessible and empowering for patients, partnering with retail chains to offer tests in regular stores.

What She Actually Did

Investigations showed that Theranos’ technology did not work as advertised and that most tests were secretly run on traditional lab machines while being presented as Theranos’ own. Holmes and other executives were accused of exaggerating the capabilities of the devices, faking demos and validation reports, and overstating financial performance to raise hundreds of millions of dollars from investors.

Legal Trouble And Conviction

Regulators charged Holmes and Theranos with fraud for raising roughly 700 million dollars through false or misleading statements about the technology and business. In a federal criminal trial, a jury found her guilty on multiple counts of wire fraud and conspiracy to commit wire fraud against investors (she was acquitted on some patient‑related counts), concluding that she intentionally deceived backers about Theranos’ capabilities and finances.

Why People Still Talk About Her

Holmes and Theranos became a global cautionary tale about startup hype, “fake it till you make it,” and the dangers of treating high‑risk medical tech like a typical Silicon Valley app. The case continues to fuel forum discussions and documentaries because it blends celebrity‑style branding, massive investor losses, and the unsettling risk that faulty tests could have harmed real patients.

TL;DR: Elizabeth Holmes built Theranos on promises that its blood‑testing technology could do far more than it really could, misled investors and others about those capabilities and the company’s finances, and was ultimately convicted of fraud for that deception.